# Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/potential-cost-savings-from-the-use-of-the-biosimilars-filgrastim-infliximab-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kerry Mansell,Hishaam Bhimji,Dean T. Eurich,Holly Mansell |
| Citations | 26 |
| DOI | 10.1186/s12913-019-4680-2 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmchealthservres.biomedcentral.com/track/pdf/10.1186/s12913-019-4680-2.pdf |
| OpenAlex ID | https://openalex.org/W2985705185 |
| PMID | 31718624 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Holly Mansell](https://scholariq.org/researchers/holly-mansell/)

## Paper journal

- [BMC Health Services Research](https://scholariq.org/journals/bmc-health-services-research/)

## Paper primary topic

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

## Paper topics

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)
- [Clostridium difficile and Clostridium perfringens research](https://scholariq.org/topics/clostridium-difficile-and-clostridium-perfringens-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.